Coronavirus Breakthrough: Pfizer may seek authorisation for its COVID-19 vaccine in mid-November

Pfizer Inc, a pharmaceutical giant has revealed plans to seek authorisation for its COVID-19 vaccine in mid-November. In statement issued on Friday, the company’s CEO Albert Bourla said: “So let me be clear, assuming positive data, Pfizer will apply for Emergency Authorization Use in the U.S. soon after the safety milestone is achieved in the … Continue reading Coronavirus Breakthrough: Pfizer may seek authorisation for its COVID-19 vaccine in mid-November